Moreover, inhibition of MAGL was shown to reduce cachexia in a mouse model of bone cancer [26] and lithium chloride-induced vomiting in shrews [61], and to abolish chemotherapy-induced neuropathy in mice [29], which should be considered as useful concomitant effects in further evaluation of MAGL inhibitors as potential cancer therapeutics. This evidence concerns the gene MGLL and bone neoplasm.